RGEN
Repligen CorporationPharmaceuticals, Biotechnology & Life Sciences
- Rank · 2025
- #478
- Final score
- 51.41
- Years on list
- 5
↗ Climbed 316 since 2021
Compare · Up to four Russell 1000 companies
Put them side by side
Select two, three, or four Russell 1000 companies to compare their overall rank, year-by-year trajectory, and scores down to the category level.
- RGEN· Repligen Corporation
- IQV· IQVIA Holdings, Inc.
- EXAS· Exact Sciences Corporation
Figure 01 · Side-by-side summary
The headline numbers
IQV
IQVIA Holdings, Inc.Pharmaceuticals, Biotechnology & Life Sciences
- Rank · 2025
- #447
- Final score
- 52.26
- Years on list
- 6
↗ Climbed 48 since 2020
EXAS
Exact Sciences CorporationPharmaceuticals, Biotechnology & Life Sciences
- Rank · 2025
- #483
- Final score
- 51.06
- Years on list
- 6
↗ Climbed 374 since 2020
Figure 02 · Rank trajectory
Where each line is going
Lower is better. The y-axis is inverted so a rising line means an improving rank. Missing years mean the company didn't make the top 100 that year.
Figure 03 · Pillar profile · 2025
Where each one wins
Latest-year ESG pillar scores, 0–100. The shaded bar shows relative strength across the selected companies for each pillar.
| Pillar | RGEN | IQV | EXAS |
|---|---|---|---|
| Climate Change | 65.6 | 78.2 | 49.2 |
| Employee Relations | 37.8 | 47.8 | 50.3 |
| Environment | 57.0 | 36.7 | 55.6 |
| Stakeholders & Society | 49.6 | 63.1 | 40.4 |
| Human Rights | 52.4 | 23.2 | 51.0 |
| Governance | 38.6 | 55.4 | 57.6 |
| Performance Rating | 49.0 | 42.9 | 64.7 |